fluoxymesterone-halotestin

fluoxymesterone

Oral contraceptives do not protect against HIV infection fluoxymesterone and other sexually transmitted diseases through.
Recommended to compile a complete medical history and conduct a thorough physical examination Before prescribing oral contraceptive patient. Surveys need to be repeated periodically, in accordance with the standards of quality obstetric care.
Before assigning the patient oral contraceptive she need to find out what herbal remedies it takes, as well as to review the information in the package insert for drugs that a woman will be taken with oral contraceptives.
In the presence of undiagnosed, persistent or recurring abnormal vaginal bleeding is necessary to exclude a malignant tumor.
after suffering a hepatitis oral contraceptive can be administered after 3 months (in severe cases after 6 months) after normalization of liver function test results.

Thromboembolic and other vascular complications
was found that the use of oral contraceptives increases the risk of thromboembolic complications, and thrombosis. Studies such as “case-control” showed that the relative risk in women using oral contraceptives compared with those who did not use these drugs, is 3: 1 for the first episode of thrombosis fluoxymesterone of superficial veins, 11: 4 for deep vein thrombosis or thromboembolism pulmonary artery and 6: 1,5 in women with diseases predisposing to thromboembolic complications. Studies have demonstrated that the relative risk is somewhat lower, about 3: 1 for new cases and about 4.5: 1 for the new cases requiring hospitalization. The risk of thromboembolic complications associated with the use of oral contraceptives, does not depend on the duration of taking these drugs and disappears after cessation of administration.
Women who use oral contraceptives, the relative risk of postoperative thromboembolic complications increased by 2-4 times. The relative risk of venous thrombosis in women with disease predisposing to this complication, a 2-fold higher than in women without such diseases. If possible, oral contraceptives should not be taken at least 4 weeks before and for two weeks after elective surgery is associated with increased risk of thromboembolism as well as during prolonged immobilization and recovery period. In the early post-natal risk of thromboembolic complications also increased, and so women who choose not to breastfeed may start taking oral contraceptives no earlier than 3 weeks after giving birth. After artificial or spontaneous abortion that took place on the 20th week of pregnancy or later, the use of hormonal contraceptives can be started either on Day 21 post-abortion or on the first day of the first spontaneous menstruation, whichever comes first.
The relative risk arterial thrombosis (eg stroke, myocardial infarction) is increased in the presence of other predisposing factors such as smoking, hypertension, hyperlipidemia, obesity, diabetes, a history of pre-eclampsia and elderly age. These severe vascular complications were observed in women who took oral contraceptives with estrogen content of 50 micrograms or more. The risk of vascular complications is less likely when using oral contraceptives containing less than high doses of estrogen and progestogen, but this assumption has not yet received solid proof.
The risk of serious cardiovascular fluoxymesterone side effects increases with age, as well as in heavy smokers. This risk is very high in smokers older than 35 years. Women using oral contraceptives should be strongly encouraged to stop smoking.
It has been reported on the increase in blood pressure in women taking oral contraceptives. Studies have shown that long-term use of estrogen in a dose of 50 micrograms or more, increasing the likelihood of blood pressure increases with age. Many women after discontinuation of oral contraceptives, blood pressure normalized. Unable to identify the differences in the frequency of hypertension in women, which in the past have taken oral contraceptives and in women who had never taken such drugs.
In women with hypertension (persistent blood pressure of 140-159 / 90-99 mm Hg. Art. ) before taking an oral contraceptive is necessary to normalize blood pressure. In the event of a major increase in use of oral contraceptives should be discontinued in blood pressure.
There have been reports of the occurrence of retinal thrombosis associated with the use of oral contraceptives. Use of oral contraceptives should be discontinued in the event of unexplained transient, partial or complete loss of vision; the appearance of the veil before the eyes, or double vision; nipple swelling of the optic nerve or the occurrence of retinal vascular changes. In such cases, an urgent need to implement fluoxymesterone appropriate diagnostic and therapeutic actions. buy anabolic steroids online bruce lee’s workout anabolic steroids online uk